Rethinking the FDA's Regulation of Mobile Medical Apps by: Scott D. Danzis and Christopher Pruitt
American Bar Association - Defending Liberty, Pursuing Justice ABA
View Cart & Check Out
ABA Web Store
                               
...the source you trust for practical legal information.
Sign In

View Cart & Check Out

Track Orders

Shipping Rates

Help

Administrative Law

Antitrust Law

Bankruptcy Law

Business Law

Career Development

Construction Law

Corporate Law

Criminal Law

Dispute Resolution

Elder Law

Environmental Law

Estate Planning

Evidence

Family Law

Financial Management

Franchise Law

Health Law

Insurance Law

Intellectual Property Law

International Law

Labor & Employment Law

Law Practice Management

Legal Technology

Litigation

Marketing

Mergers & Acquisitions

Professional Responsibility

Real Estate Law

Securities Law

Taxation

Tort Law

Advanced Search
Site Map

Rethinking the FDA's Regulation of Mobile Medical Apps by: Scott D. Danzis and Christopher Pruitt

Rethinking the FDA's Regulation of Mobile Medical Apps by: Scott D. Danzis and Christopher Pruitt
Product Code: 54580000903PDFA12
Authors: Scott D. Danzis, Christopher Pruitt
Sponsoring Entities: Section of Science & Technology Law
Format: PDF - 54580000903PDFA12
Pricing: $19.95 (Regular)
$14.95 (ABA Member) ABA Members, Log in now to receive this discount!
$0.00 (Section of Science & Technology Law) ABA Members, Log in now to receive this discount!
Quantity:
 
Abstract

The rapidly growing universe of mobile apps means that the FDA should take short- and long-term steps to clarify and streamline its regulatory policies, including the process of classifying apps into its risk-based tier system.
Accessing Your Download after Purchase

Immediately after checkout, the download file(s) will be available in Your Downloads (accessible in the left navigation area of the Web Store when logged in).